Patent · US Active

Compositions and methods for treating cancer

US8329666B2 · kind B2 · utility

6Cited by
26References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2010
Grant dateDec 11, 2012
Priority date
Expiry dateAug 18, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods of treating cancer comprising administering decitabine in combination with compounds that inhibit the deamination enzyme responsible for the inactivation of decitabine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.